Skip to main content
Premium Trial:

Request an Annual Quote

NHLBI Earmarks $1.2M over Three Years to Fund Short Courses in Genomics, Proteomics

NEW YORK, Aug. 15 (GenomeWeb News) - The National Heart, Lung, and Blood Institute is seeking applicants to develop short courses on the application of genomics and proteomics to heart, lung, blood, and sleep disorders.


NHLBI issued a request for applications for the program, entitled "Short Courses on Application of Genomics and Proteomics to Complex Heart, Lung, Blood, and Sleep Disorders," on Aug. 10.


The institute intends to spend around $1.2 million on the program through 2009, with $300,000 allocated for 2006. NHLBI said it expects to fund 1 or 2 grants under the program.


NHLBI said in the RFA that the courses "should provide hands-on training to investigators interested in leveraging genomic and proteomic technologies and resources to advance the understanding of disease mechanisms of interest to the institute."


Letters of intent are due on Dec. 19, and applications are due Jan. 17, 2006.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more